These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

351 related items for PubMed ID: 11751994

  • 21. The tyrosine phosphatase Shp2 interacts with NPM-ALK and regulates anaplastic lymphoma cell growth and migration.
    Voena C, Conte C, Ambrogio C, Boeri Erba E, Boccalatte F, Mohammed S, Jensen ON, Palestro G, Inghirami G, Chiarle R.
    Cancer Res; 2007 May 01; 67(9):4278-86. PubMed ID: 17483340
    [Abstract] [Full Text] [Related]

  • 22. TrkA is a binding partner of NPM-ALK that promotes the survival of ALK+ T-cell lymphoma.
    Shi W, George SK, George B, Curry CV, Murzabdillaeva A, Alkan S, Amin HM.
    Mol Oncol; 2017 Sep 01; 11(9):1189-1207. PubMed ID: 28557340
    [Abstract] [Full Text] [Related]

  • 23. Expression of anaplastic lymphoma kinase in non-Hodgkin's lymphomas and other malignant neoplasms. Biological, diagnostic, and clinical implications.
    Wasik MA.
    Am J Clin Pathol; 2002 Dec 01; 118 Suppl():S81-92. PubMed ID: 14569815
    [Abstract] [Full Text] [Related]

  • 24. NPM-ALK transgenic mice spontaneously develop T-cell lymphomas and plasma cell tumors.
    Chiarle R, Gong JZ, Guasparri I, Pesci A, Cai J, Liu J, Simmons WJ, Dhall G, Howes J, Piva R, Inghirami G.
    Blood; 2003 Mar 01; 101(5):1919-27. PubMed ID: 12424201
    [Abstract] [Full Text] [Related]

  • 25. Oncogenic tyrosine kinase NPM/ALK induces activation of the MEK/ERK signaling pathway independently of c-Raf.
    Marzec M, Kasprzycka M, Liu X, Raghunath PN, Wlodarski P, Wasik MA.
    Oncogene; 2007 Feb 08; 26(6):813-21. PubMed ID: 16909118
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Silibinin suppresses NPM-ALK, potently induces apoptosis and enhances chemosensitivity in ALK-positive anaplastic large cell lymphoma.
    Molavi O, Samadi N, Wu C, Lavasanifar A, Lai R.
    Leuk Lymphoma; 2016 May 08; 57(5):1154-62. PubMed ID: 26133723
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Loss of SHP1 enhances JAK3/STAT3 signaling and decreases proteosome degradation of JAK3 and NPM-ALK in ALK+ anaplastic large-cell lymphoma.
    Han Y, Amin HM, Franko B, Frantz C, Shi X, Lai R.
    Blood; 2006 Oct 15; 108(8):2796-803. PubMed ID: 16825495
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. The transcription factors Ik-1 and MZF1 downregulate IGF-IR expression in NPM-ALK⁺ T-cell lymphoma.
    Vishwamitra D, Curry CV, Alkan S, Song YH, Gallick GE, Kaseb AO, Shi P, Amin HM.
    Mol Cancer; 2015 Feb 25; 14():53. PubMed ID: 25884514
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. The heat shock protein-90 co-chaperone, Cyclophilin 40, promotes ALK-positive, anaplastic large cell lymphoma viability and its expression is regulated by the NPM-ALK oncoprotein.
    Pearson JD, Mohammed Z, Bacani JT, Lai R, Ingham RJ.
    BMC Cancer; 2012 Jun 08; 12():229. PubMed ID: 22681779
    [Abstract] [Full Text] [Related]

  • 39. β-catenin is constitutively active and increases STAT3 expression/activation in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma.
    Anand M, Lai R, Gelebart P.
    Haematologica; 2011 Feb 08; 96(2):253-61. PubMed ID: 20971814
    [Abstract] [Full Text] [Related]

  • 40. The expression of CD30 in anaplastic large cell lymphoma is regulated by nucleophosmin-anaplastic lymphoma kinase-mediated JunB level in a cell type-specific manner.
    Hsu FY, Johnston PB, Burke KA, Zhao Y.
    Cancer Res; 2006 Sep 15; 66(18):9002-8. PubMed ID: 16982741
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.